Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TY1Y
|
|||
| Drug Name |
PfSPZ-Cvac
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-9: 84] | Phase 2 | [1] | |
| Company |
Sanaria Rockville, MD
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03503058) Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.